CONTEXT: Dr. Francis Blankenberg and colleagues at Stanford University's nuclear medicine department have developed a nondestructive way, based on two fragments of human RNAse I, to radiolabel the tumor angiogenesis marker VEGF (vascular endothelial growth factor). The larger and sturdier standardized fragment, the "adapter protein," is radiolabeled with technetium-99m. It is then simply mixed with a fusion protein consisting of the smaller complementary fragment, the "docking tag," and targeting protein VEGF. The two proteins self-assemble into a Tc-99m-VEGF targeting complex for radionuclide imaging.
RESULTS: Using bioluminescent imaging (BLI) and radionuclide imaging, the researchers tracked the growth of subcutaneous and lung tumors in mice implanted or injected with luciferase-expressing murine mammary adenocarcinoma cells. One hour after injecting the tracer, planar images were acquired that showed significantly increased uptake of VEGF compared with the single-chain Hu-P4G7 anti-VEGF-R2 antibody radiolabeled complexes. Both tracers bound to the VEGF-R2 receptor, but only VEGF was internalized into tumor endothelial cells.
IMAGE: A: Planar whole-body BLI of mouse with right shoulder tumor. B: Radionuclide image of same mouse after injection of Tc-99m-HuS/Hu-VEGF. C: Radionuclide image of mouse with left shoulder tumor after injection of Tc-99m-HuS/Hu-P4G7. D: BLI of same mouse.
IMPLICATIONS: The VEGF imaging complex is stable and capable of routinely targeting lesions of about 1 mm in diameter in vivo. The Stanford team expects to develop a similar approach for delivery of other targeting proteins, according to Blankenberg.
"It is anticipated that this technique could be used to create a library of fusion proteins, all of which could be rapidly and nondestructively labeled using the identical radiochemistry," he said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.